THE WHAT? Natura &Co is rumored to be weighing the possibility of offloading its Avon International unit. The Brazilian beauty giant, which has already sold Aesop to L’Oreal and struck a deal for The Body Shop in the last year, is said to be keen to focus on its home market.
THE DETAILS According to a report published by the Financial Times, quoting sources ‘familiar with the matter’, Natura &Co is mulling retaining the direct sales brand’s Latin American business, while selling or spinning off the remainder.THE WHY? Natura &Co declined to comment when contacted by the Financial Times but it is possible that, after a tricky couple of years that has seen share prices drop in the face of disappointing financial results, the Brazilian behemoth is regretting its 2017 to 2019 shopping spree.
Aesthetic supplies USA refers to products and equipment used in the field of aesthetic medicine and cosmetic treatments that are available for purchase in the United States. These supplies encompass a wide range of items necessary for various aesthetic procedures and treatments conducted by professionals such as dermatologists, plastic surgeons, aestheticians, and other qualified practitioners.
Examples of aesthetic supplies include:
-
Dermal Fillers: Injectable substances used to restore volume and reduce wrinkles.
-
Botulinum Toxin (Botox): Injectables used to temporarily relax facial muscles and reduce wrinkles.
-
Laser Devices: Equipment used for hair removal, skin rejuvenation, tattoo removal, and other laser treatments.
-
Chemical Peels: Solutions applied to the skin to exfoliate and improve texture.
-
Microdermabrasion Devices: Tools used for mechanical exfoliation to rejuvenate skin.
-
Microneedling Devices: Devices that create tiny punctures in the skin to stimulate collagen production.
-
Cosmeceuticals: Skincare products that contain biologically active ingredients with pharmaceutical-like benefits.
-
Sterilization and Disinfection Products: Essential for maintaining hygiene and preventing infections in clinical settings.
